cultivate (MD) Capital Funds Portfolio Company Virtual Incision Submits FDA De Novo Request for Market Authorization of MIRA
Grand Rapids, Mich., May 22, 2023— cultivate(MD) Capital Funds LP, funds that are focused on investments into early-stage healthcare companies with innovative technologies, announced today that one of their portfolio companies, Lincoln, Nebraska-based Virtual Incision Corporation, has submitted a De Novo request to the U.S. Food and Drug Administration (FDA) to market its MIRA Surgical […]